Abiopharma

🔍 DiMaio John Michael (Director)

Company: Spectral AI, Inc. (MDAI)

Report Date: 2026-08-13

Detailed Transactions and Holdings:

• Acquired 35,000 shares of Common Stock at $1.64 per share (Direct)
  Date: 2026-08-13 | Code: A | equity_swap_involved: 0 | shares_owned_after: 2,766,847.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 5,292 shares of ISO at $1.67 per share (Derivative)
  Date: 2026-08-13 | Code: H | Expires: 2034-05-15 | shares_owned_after: 5,292.00 | Footnotes: F2
• Holds 20,352 shares of ISO at $1.67 per share (Derivative)
  Date: 2026-08-13 | Code: H | Expires: 2034-05-15 | shares_owned_after: 20,352.00 | Footnotes: F3
• Holds 250,000 shares of NQSO at $1.25 per share (Derivative)
  Date: 2026-08-13 | Code: H | Expires: 2035-04-23 | shares_owned_after: 250,000.00 | Footnotes: F4
• Holds 100,000 shares of Restricted Stock Unit at $1.84 per share (Derivative)
  Date: 2026-08-13 | Code: H | Expires: 2036-04-20 | shares_owned_after: 100,000.00 | Footnotes: F5

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
• F2: 100% of the stock options vested on the date of issuance.
• F3: 100% of the stock options were vested as of the date hereof.
• F4: 100,000 of the stock options were vested as of the date hereof. The remaining 150,000 stock options vest upon the achievement of certain milestones.
• F5: 50% of the RSUs vested on April 20, 2026. 50% of the RSUs will vest on April 1, 2027.